Stock UniverseDerived research view · source repositories remain read-only

Fennec Pharmaceuticals Inc. (FENC)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
29.53
Global Rank
2092
Market Cap
289.96M
Latest Close
8.70
RS Composite
8.83% · G#805

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
21.17%
3M
12.99%
6M
14.93%
1Y
13.36%
3Y
14.78%
5Y
18.05%
10Y
-27.50%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 168.18K · 30-day average: 313.97K · Max drawdown over stored range: -76.97%

Research Snapshot

Relative Strength vs SPX

RS Composite8.83%
20D RS25.45%
60D RS0.19%
120D RS9.16%
Global RS Rank805 · 76.01% percentile
Watch+Speculative RS Rank491 · 76.59% percentile
Group ScopeWatch+Speculative
Primary RS Rank94 · 79.48% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank325 / 701
Primary Percentile53.78
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for FENC.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0.1701.53521.25247.53844.642
Revenue Growth (YoY)3000%3000%3000%1284.495%123.687%-6.092%
Gross Profit0.1701.44919.99344.354
Operating Income-17.885-17.223-22.589-12.7712.568
Free Cash Flow-14.222-18.058-17.14326.98-12.473
Free Cash Flow Per Share-0.546874-0.687269-0.6451040.988495640067414-0.4364698883717675
EPS (Diluted) GAAP-0.763963-0.67-0.90253-0.603785-0.02
EPS Growth
EPS Non-GAAP
Gross Margin100%3000%94.397%94.076%93.302%91.5685%
Operating Margin-10520.588%3000%-1471.596%-60.093%5.402%-14.072%
Profit Margin-10652.353%3000%-1544.886%-75.499%-0.917%-21.8203%
Free Cash Flow Margin-1176.42%-80.6653%56.7546%-27.9401%
Shares Outstanding (Diluted)23.70426.00626.27526.57427.29428.577
Shares Change (YoY)19.14%9.711%1.034%1.138%2.709%4.701%

SEC Quarterly Fundamentals

No processed quarterly rows for FENC.